Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 25, Issue 5, 2010, Pages 715-719

  Kockar, Feray ^a   Sinan, Selma ^a   Yildirim, Hatice ^a   Arslan, Oktay ^a  

^a BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Antibiotics; HEPG2; IC50; Inhibition; PON1

Indexed keywords

AMPICILLIN; ARYLDIALKYLPHOSPHATASE; CIPROFLOXACIN; CLINDAMYCIN PHOSPHATE; HYDROLYASE; RIFAMYCIN SV DERIVATIVE;

ARTICLE; DOSE RESPONSE; DRUG INHIBITION; DRUG STRUCTURE; ENZYME ACTIVITY; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ARYLDIALKYLPHOSPHATASE; CIPROFLOXACIN; CLINDAMYCIN; HEP G2 CELLS; HEPATOCYTES; HUMANS; KINETICS; OSMOLAR CONCENTRATION; RIFAMYCINS;

EID: 77956031225     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756360903555266     Document Type: Article

References (25)

1. Durringhton PN, Mackness B, Mackness MJ. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-480
2. Primo Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498-507.
3. La Du BN, Aviram N, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999;119-120: 379-388.
4. Mochizuki H, Scherer SW, Xi T, Nickle DJ, Majer M, Huizenga JJ, Tsui LC, Prochazka M. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 1998;213:149-157.
5. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334-336.
6. Aldridge WN. Serum esterases.II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem J 1953;53:117-124.
7. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, La Du BN. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 2000;28:1335-1342.
8. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000;275:3957-3962.
9. Sinan S, Kockar F, Gencer N, Yildirim H, Arslan O. Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma Cells (HepG2) in vitro. Biochemistry (Moscow) 2006;71:46-50.
10. Sinan S, Kockar F, Gencer N, Yildirim H, Arslan O. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo. Biol Pharm Bull 2006;29:1559-1563.
11. Sinan S, Kockar F, Arslan O. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics. Biochimie 2006;88:565-574.
12. Farag SA. Simultaneous liquid chromatographic analysis of the beta lactam antibiotics cefazolin, cefadroxil, cepalexin, ampicillin, and cephradine in solution. J AOAC Int 1998;81:381-385.
13. Sen S, Jaiswal AK, Yanpallewar S, Acharya SB. Anxiogenic potential of ciprofloxacin and norfloxacin in rats. Singapore Med J 2007;48:1028.
14. Yu H, Yao Y, Liu Y, Jiao R, Jiang W, Zhao GP. A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production. Arch Microbiol 2007;188:89-96.
15. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-106.
16. Foka P, Irvine SA, Kockar F, Ramji DP. Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region. Nucleic Acids Res 2003;31:6722-6732.
17. Bergheanu SC, Van Tol A, Dallinga-Thie GM, Liem A, Dunselman PH, Van der Bom JG, Jukema JW. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol. Curr Med Res Opin 2007;23:2235-2240.
18. Tougou K, Nakamura A, Watanabe S, Okuyama Y, Morino A. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos 1998;26:355-359.
19. Bolayirli IM, Aslan M, Balci H, Altug T, Hacibekiroglu M, Seven A. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sciences 2007;81:121-127.
20. Malin R, Laaksonen R, Knuuti J, Janatuinen T, Vesalainen R, Nuutila P, Lehtimäki T. Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol. Pharmacogenetics 2001;11:625-633.
21. Kiranoglu S, Sinan S, Gencer N, Kockar F, Arslan O. In Vivo effects of oral contraceptives on paraoxonase, catalase and carbonic anhydrase enzyme activities on mouse. Biol Pharm Bull 2007;30:1048-1051.
22. Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, Covas M, Marrugat J. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2000;20:2113-2119.
23. Leviev I, James R. Simvastatin increases plasma levels of the antioxidant enzyme paraoxonase by PON1 gene activation. Atherosclerosis 2000;151:41.
24. Gouedard C, Koum-Besson N, Barouki R, Morel Y. Opposite regulation of the human paraoxonase-1 gene PON1 by fenofibrate and statins. Mol Pharmacol 2003;63:945.
25. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, La Du BN. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities. Selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 1998;18:1617.